Skip to content
MRK·NYSE·US

Merck

Merck is a global healthcare company that sells prescription medicines, vaccines, biologic therapies, and animal health products. Its portfolio is led by oncology and vaccine products, with a separate animal health segment serving companion animals and livestock.

Recent Activity

Updated Oct 31, 2026
–Merck topped third-quarter estimates and raised its profit outlook, with Keytruda, including its newer injectable form, posting stronger-than-expected sales.
–A personalized melanoma vaccine developed by Moderna and Merck, combined with Keytruda, cut the risk of relapse or death by 42% in a landmark melanoma study.
–Merck was recognized as a launch partner, alongside BD, at the ribbon-cutting for CMMB's new distribution center at the Brethren Service Center.

Past updates are part of the Pro plan.

Thematic Position

Relationship Groups

Suppliers4
Customers5
Partners14
Licensing4
Competitors30

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

17 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

price controlgovernment price-setting
U.S. IRA Drug Price Negotiation Program sets prices for Januvia, Janumet, Lenvima, and Keytruda
SEC 10-QAug 7, 2026

The full regulatory passage is part of the Pro plan.

64 more · Regulatory and geopolitical insights are part of the Pro plan.

Related Events

1 event · Related events are part of the Pro plan.